{"id":"methyl-prednisolone-mp","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Insomnia"},{"rate":"5-10%","effect":"Increased appetite"},{"rate":"5-10%","effect":"Weight gain"},{"rate":"1-5%","effect":"Osteoporosis"},{"rate":"1-5%","effect":"Glaucoma"},{"rate":"1-5%","effect":"Cataracts"},{"rate":"1-5%","effect":"Hypokalemia"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It works by binding to glucocorticoid receptors in the cytoplasm, which then translocate to the nucleus and inhibit the transcription of inflammatory genes. This leads to a decrease in the production of pro-inflammatory cytokines, such as IL-1, IL-6, and TNF-alpha, resulting in reduced inflammation and immune response.","oneSentence":"Methylprednisolone is a synthetic corticosteroid that suppresses the immune system by inhibiting the production of inflammatory cytokines.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:50:03.517Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Severe asthma attacks"},{"name":"Severe allergic reactions (anaphylaxis)"},{"name":"Severe skin conditions (such as psoriasis or eczema)"},{"name":"Severe inflammatory conditions (such as rheumatoid arthritis or lupus)"}]},"trialDetails":[{"nctId":"NCT07317596","phase":"PHASE3","title":"Comparing Methylprednisolone And Hyaluronic Acid To Reduce Wisdom Tooth Surgery Complications","status":"ENROLLING_BY_INVITATION","sponsor":"Sana'a University","startDate":"2024-06-27","conditions":"Wisdom Tooth Removal, Post Operative Complications, Hyaluronic Acid","enrollment":40},{"nctId":"NCT07175623","phase":"NA","title":"Methylprednisolone vs Dexamethasone Interaction With Sugammadex in Pediatric Patients","status":"COMPLETED","sponsor":"Konya City Hospital","startDate":"2025-09-16","conditions":"Neuromuscular Block, Residual, Pain Management, Postoperative Nausea","enrollment":60},{"nctId":"NCT02472054","phase":"PHASE1, PHASE2","title":"Treatment of Familiar Lymphohistiocytosis","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-06-29","conditions":"Hemophagocytic Lymphohistiocytosis (HLH)","enrollment":29}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Methyl Prednisolone (MP)","genericName":"Methyl Prednisolone (MP)","companyName":"Sana'a University","companyId":"sana-a-university","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Methylprednisolone is a synthetic corticosteroid that suppresses the immune system by inhibiting the production of inflammatory cytokines. Used for Severe asthma attacks, Severe allergic reactions (anaphylaxis), Severe skin conditions (such as psoriasis or eczema).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}